drugset / Trial / NCT06672172

A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise

NCT06672172

Phase 3 Completed 284 enrolled Shandong Suncadia Medicine Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this trial is to evaluate the efficacy and safety of HRS-7535 compared with placebo in subjects with type 2 diabetes mellitus with inadequate glycemic control with diet and exercise

Timeline

Start
2024-09-25
Primary completion
2025-11-13
Completion
2026-04-17

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-7535 Small molecule Oral